mMCQ.

Navigation Menu

Step into mMCQ.

Launch mMCQ. diagnostic

Explore mMCQ.

MDCAT prepFree DiagnosticPricing & SubscribeSign in

Resources

Terms & Conditions

mMCQ.

© 2021 - 2025 mMCQ.All rights reserved.

WhatsApp
O Levels Biology (5090)•5090/11/O/N/24
Question 36 from 5090/11/O/N/24

Explanation

Recombinant insulin avoids animal-derived risks

Steps:

  • Identify the type: This refers to human insulin produced via recombinant DNA technology in bacteria or yeast, mimicking the human protein exactly.
  • Compare to alternatives: Traditional insulin came from animal pancreases (pigs, cows), which could cause immune reactions.
  • Evaluate advantages: Recombinant method produces pure human insulin, reducing side effects like allergies or impurities.
  • Match to choices: Select the option highlighting elimination of animal insulin issues.

Why D is correct:

  • Recombinant insulin is identical to human insulin, eliminating side effects from animal proteins due to antigenic differences, as per immunology principles of foreign protein rejection.

Why the others are wrong:

  • A: Genetic therapy doesn't alter patient's germline DNA, so offspring aren't protected.
  • B: This production method supplies external insulin; it doesn't repair or stimulate the patient's pancreas.
  • C: The insulin gene is inserted into host cells (e.g., bacteria) for production, not into the patient's DNA.

Final answer: D

Topic: Genetic modification

Practice more O Levels Biology (5090) questions on mMCQ.me